Skip to main content

Trexquant Investment LP

Position in MYGN — Myriad Genetics Inc

CIK 1633445 STAMFORD, CT

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,827,459
-$1,508,885 QoQ
Shares Held
406,102
-25.1% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $87,777,569 across 14 Diagnostics & Research names. MYGN ranks #11 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,827,459 406,102
2025-12-31 $3,336,344 542,495
2025-09-30 $2,886,881 399,292
2025-03-31 $952,912 107,431
2024-12-31 $1,266,474 92,376
2024-09-30 $3,696,143 134,945
2024-06-30 $5,154,871 210,747
2023-06-30 $639,860 27,604
2023-03-31 $1,368,339 58,904
2022-12-31 $275,080 18,958
2020-12-31 $253,253 12,810